NCT02626923View on ClinicalTrials.gov

Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Drug-induced Hypotension
Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Nicholaos C Bellos, MD

OTHER

NCT02626923 - Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients | Biotech Hunter | Biotech Hunter